HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer Faber Selected Research

Ataxia (Dyssynergia)

11/2023Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3.
10/2023Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3.
9/2023Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L.
8/2023Correction to: MR Imaging in Ataxias: Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers.
6/2023Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy.
6/2023MR Imaging in Ataxias: Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers.
4/2023Stage-dependent biomarker changes in spinocerebellar ataxia type 3.
1/2023Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
1/2023Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative Ataxia.
1/2023A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer Faber Research Topics

Disease

13Ataxia (Dyssynergia)
11/2023 - 01/2022
9Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
11/2023 - 01/2020
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
11/2023 - 01/2023
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2017
1Nervous System Diseases (Neurological Disorders)
01/2024
1Friedreich Ataxia (Friedreich's Ataxia)
09/2023
1CANVAS syndrome
06/2023
1Restless Legs Syndrome (Restless Legs)
02/2023
1Ganglion Cysts (Ganglion)
01/2022
1Bacterial Infections (Bacterial Infection)
10/2020
1Stuttering (Stammering)
01/2019
1Temporal Lobe Epilepsy
07/2009
1Sclerosis
07/2009
1Partial Epilepsies (Epilepsy, Partial)
07/2009

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2017
3Ataxin-3IBA
10/2023 - 11/2021
2polyglutamineIBA
10/2023 - 11/2021
2Retinaldehyde (Retinal)IBA
01/2022 - 01/2022
2Amyloid (Amyloid Fibrils)IBA
01/2017 - 01/2017
1AntibodiesIBA
01/2024
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2024
1indium arsenide (InAs)IBA
09/2023
1fibroblast growth factor 14IBA
06/2023
1SulfamethoxazoleFDA LinkGeneric
10/2020
1Trimethoprim (Proloprim)FDA LinkGeneric
10/2020
1Thymidine Monophosphate (TMP)IBA
10/2020
1Therapeutic UsesIBA
01/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2009

Therapy/Procedure

3Activities of Daily Living (ADL)
09/2023 - 12/2022
2Therapeutics
06/2023 - 07/2009